Clinical Outcomes Based on Measurable Residual Disease Status in Patients with Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Measurable residual disease (MRD) response during acute myeloid leukemia (AML) treatment is a gold standard for determining treatment strategy, especially in core-binding factor (CBL) AML. The aim of this study was to critically review the literature on MRD status in the CBF-AML to determine the ove...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of personalized medicine 2020-11, Vol.10 (4), p.250
Hauptverfasser:	Rotchanapanya, Wannaphorn, Hokland, Peter, Tunsing, Pattaraporn, Owattanapanich, Weerapat
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute myeloid leukemia Chemotherapy Clinical outcomes Leukemia Medical prognosis Meta-analysis Myeloid leukemia Patients Polymerase chain reaction Precision medicine Survival Systematic review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!